Connect with us

Health

Half of Americans not equipped to provide life-saving treatment in a crisis, poll finds

Published

on

Half of Americans not equipped to provide life-saving treatment in a crisis, poll finds

Join Fox News for access to this content

Plus special access to select articles and other premium content with your account – free of charge.

Please enter a valid email address.

By entering your email and pushing continue, you are agreeing to Fox News’ Terms of Use and Privacy Policy, which includes our Notice of Financial Incentive. To access the content, check your email and follow the instructions provided.

Having trouble? Click here.

Only half the people in the U.S. feel they could be helpful in an emergency situation, a new poll found.

The Ohio State University Wexner Medical Center surveyed a national sample of 1,005 Americans, finding that only 51% of them knew how to perform hands-only CPR if needed.

Advertisement

In cases of serious bleeding, only 49% said they could assist, and 56% said they would be equipped to help someone who was choking.

The data was collected via phone and email from April 5 to April 7 of this year.

KIDS AS YOUNG AS 4 YEARS OLD CAN BEGIN TO LEARN MEDICAL EMERGENCY TRAINING: NEW REPORT

“The key takeaways from our survey are that patient outcomes would improve if the general public learned some basic life-saving measures in the areas of hands-only CPR, choking rescue and bleeding control,” Nicholas Kman, M.D., emergency medicine physician at Ohio State Wexner Medical Center and clinical professor of emergency medicine at The Ohio State University College of Medicine, told Fox News Digital.  

“We can save lives while we wait for first responders to arrive.”

Advertisement

Only half the people in the U.S. feel they could be helpful in an emergency situation, a new poll has found. (iStock)

“For every minute that passes, the chance of survival drops, and if they do survive, there’s less chance of a good neurologic outcome.”

Data shows that 70% to 80% of cardiac arrests occur in the home and 20% happen in a public place, according to Kman.

HELP DESPERATELY NEEDED: AMERICAN HEART ASSOCIATION LAUNCHES ‘NATION OF LIFESAVERS’ PROGRAM

“Outcomes are poor when the arrest is unwitnessed at home,” he told Fox News Digital.  

Advertisement

“Just think, the person with the medical emergency could be your loved one in your house. You may have to provide life-saving treatment until first responders arrive.”

Data shows that 70% to 80% of cardiac arrests occur in the home and 20% happen in a public place, a researcher said. (iStock)

Based on the survey findings, Kman advised the public to get trained in life-saving measures — particularly hands-only CPR, choking and serious bleeding.

“Look for training that may be offered through community days at hospitals, schools, libraries, community organizations, religious institutions, volunteer groups, festivals and sporting events,” he suggested.

“We’re responsible for each other.”

Advertisement

Organizations and websites such as the American Red Cross, the American Heart Association and Stop The Bleed may offer these courses for free or low cost, Kman noted.  

After learning the skills, it’s important to practice them, the doctor said.

“We would love the public to learn how to do hands-only CPR and practice the skill of doing CPR every six weeks,” Kman said.

Based on the survey findings, researchers advised people to get trained in life-saving measures, particularly hands-only CPR, choking first-aid and serious bleeding assistance. (iStock)

“As with any skill, practice builds confidence. If we don’t practice it, we lose that skill.”

Advertisement

The OSU survey did have some limitations, Kman acknowledged.

“The survey was a convenience sample of a cross-section of Americans,” he told Fox News Digital. 

HEART ATTACKS MORE LIKELY DURING PRESIDENTIAL ELECTIONS AND OTHER STRESSFUL TIMES, STUDY SHOWS

“Most demographics were equally represented, but different regions do better at this than others, and their cardiac arrest results and survival reflect that,” he continued. 

“States and countries that prioritize training the public have higher survival rates.”

Advertisement

“When you’re trained in these lifesaving skills, you’ll know how to recognize the signs that someone needs help and buy time until the [first] responders can get there,” a doctor said. (iStock)

Dr. Kenneth Perry, an emergency department physician in South Carolina, was not involved in the survey but said he was surprised that more people don’t feel unprepared.

“Even for medical professionals, having a medical emergency occur without preparation can be a very stressful event,” he told Fox News Digital. 

“It is very important for people to have basic lifesaving skills.”

“It is very important for people to have basic lifesaving skills.”

Advertisement

The easiest and most helpful skill that people should learn is how to operate an automated external defibrillator (AED). These are located in many public places, such as gyms, malls and even some public walkways, according to Perry.  

“These devices are the best way to save a person who is suffering from cardiac arrest,” he said.

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

“If the person has an abnormal heart rhythm that can be brought back to normal with electricity, this device will save that patient.”

This is a very time-sensitive process, however — it must happen as early as possible, the doctor advised. 

Advertisement

“Early defibrillation is directly correlated with the best outcomes for patients who suffer an out-of-hospital cardiac arrest.”

Ultimately, Kwan, said, “we’re responsible for each other.”

“When you’re trained in these lifesaving skills, you’ll know how to recognize the signs that someone needs help and buy time until the responders can get there.”

For more Health articles, visit www.foxnews.com/health.

Advertisement

Health

Aging process could accelerate due to ‘forever chemicals’ exposure, study finds

Published

on

Aging process could accelerate due to ‘forever chemicals’ exposure, study finds

NEWYou can now listen to Fox News articles!

A new study suggests that middle-aged men may be more vulnerable to faster biological aging, potentially linked to exposure to “forever chemicals.”

The research, published in the journal Frontiers in Aging, examined how perfluoroalkyl and polyfluoroalkyl substances, more commonly known as PFAS, could impact aging at the cellular level.

PFAS are synthetic chemicals commonly used in nonstick cookware, food packaging, water-resistant fabrics and other consumer products, the study noted. 

Their chemical structure makes them highly resistant to breaking down, allowing them to accumulate in water, soil and the human body.

Advertisement

Chinese researchers analyzed blood samples from 326 adults enrolled in the U.S. National Health and Nutrition Examination Survey between 1999 and 2000.

A new study suggests that middle-aged men could face accelerated biological aging at the cellular level due to exposure to PFAS. (iStock)

The researchers measured levels of 11 PFAS compounds in participants’ blood and used DNA-based “epigenetic clocks” — tools that analyze chemical changes to DNA to estimate biological age — to determine how quickly their bodies were aging at the cellular level, the study stated.

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

Two compounds, perfluorononanoic acid (PFNA) and perfluorooctanesulfonamide (PFOSA), were detected in 95% of participants.

Advertisement

Higher concentrations of those chemicals were associated with faster biological aging in men of certain age groups, but not in women.

“People should not panic.”

The compounds most strongly linked to accelerated aging were not the PFAS chemicals that typically receive the most public attention, the researchers noted.

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

“The associations were strongest in adults aged 50 to 64, particularly in men,” Dr. Xiangwei Li, professor at Shanghai Jiao Tong University School of Medicine and the study’s corresponding author, told Fox News Digital. 

Advertisement

“While this does not establish that PFAS cause aging, it suggests that these widely present ‘forever chemicals’ may be linked to molecular changes related to long-term health and aging.”

The study found that two of the compounds were detected in 95% of participants, and higher levels were linked to faster biological aging in men ages 50–64. (iStock)

Midlife may represent a more sensitive biological period, when the body becomes more vulnerable to age-related stressors, according to the researchers.

Lifestyle factors, such as smoking, may influence biological aging markers, potentially increasing vulnerability to environmental pollutants.

Advertisement

While Li said “people should not panic,” she does recommend looking for reasonable ways to reduce exposure. 

That might mean checking local drinking water reports, using certified water filters designed to reduce PFAS, and limiting the use of stain- or grease-resistant products when alternatives are available.

CLICK HERE FOR MORE LIFESTYLE STORIES

Meaningful reductions in PFAS exposure will likely depend on broader regulatory action and environmental cleanup efforts, Li added.

The researchers noted that midlife could be a particularly sensitive stage, when the body is more susceptible to stressors associated with aging. (iStock)

Advertisement

Study limitations

The researchers outlined several important limitations of the research, including that the findings show an association, but do not prove that PFAS directly causes accelerated aging.

“The study is cross-sectional, meaning exposure and aging markers were measured at the same time, so we cannot determine causality,” Li told Fox News Digital.

The study was also relatively small, limited to 326 adults age 50 or older, which means the findings may not apply to younger people or broader populations.

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

Researchers measured PFAS levels using data collected between 1999 and 2000, and today’s exposure patterns may differ.

Advertisement

Li added that while PFAS is known to persist in the environment and the body, these results should be validated through larger, more recent studies that follow participants over time.

Related Article

Nightly bathroom habit was missed sign of common men's cancer: 'I didn't know'
Continue Reading

Health

Melissa Joan Hart, 49, Opens up About Weight Loss in Perimenopause

Published

on

Melissa Joan Hart, 49, Opens up About Weight Loss in Perimenopause


Advertisement




Melissa Joan Hart Opens up About Weight Loss in Perimenopause | Woman’s World




















Advertisement





Advertisement


Use left and right arrow keys to navigate between menu items.


Use escape to exit the menu.

Advertisement

Continue Reading

Health

Alzheimer’s prevention breakthrough found in decades-old seizure drug

Published

on

Alzheimer’s prevention breakthrough found in decades-old seizure drug

NEWYou can now listen to Fox News articles!

A drug that has long been used to treat seizures has shown promise as a potential means of Alzheimer’s prevention, a new study suggests.

The anti-seizure medication, levetiracetam, was first approved by the FDA in November 1999 under the brand name Keppra as a therapy for partial-onset seizures in adults. The approval has since expanded to include children and other types of seizures.

Northwestern University researchers recently found that levetiracetam prevented the formation of toxic amyloid beta peptides, which are small protein fragments in the brain that are commonly seen in Alzheimer’s patients.

The medication was found to prevent the formation of amyloid-beta 42 in both animal models and cultured human neurons, according to the study findings, which were published in Science Translational Medicine.

Advertisement

The effect was also seen in post-mortem human brain tissue obtained from individuals with Down syndrome, who are at high risk for Alzheimer’s disease.

The medication was found to prevent the formation of amyloid-beta 42 in both animal models and cultured human neurons. (iStock)

“While many of the Alzheimer’s drugs currently on the market, such as lecanemab and donanemab, are approved to clear existing amyloid plaques, we’ve identified this mechanism that prevents the production of the amyloid‑beta 42 peptides and amyloid plaques,” said corresponding author Jeffrey Savas, associate professor of behavioral neurology at Northwestern University Feinberg School of Medicine, in a press release. 

“Our new results uncovered new biology while also opening doors for new drug targets.”

HIDDEN BRAIN CONDITION MAY QUADRUPLE DEMENTIA RISK IN OLDER ADULTS, STUDY SUGGESTS

Advertisement

The brain is better able to avoid the pathway that produces toxic amyloid‑beta 42 proteins in younger years, but the aging process gradually weakens that ability, Savas noted. 

“This is not a statement of disease; this is just a part of aging. But in brains developing Alzheimer’s, too many neurons go astray, and that’s when you get amyloid-beta 42 production,” he said. 

The effect was also seen in post-mortem human brain tissue obtained from individuals with Down syndrome, who are at high risk for Alzheimer’s disease. (iStock)

That then leads to tau (“tangles”) — abnormal clumps of protein inside brain neurons — which can kill brain cells, trigger neuroinflammation and lead to dementia.

In order for levetiracetam to function as an Alzheimer’s blocker, high-risk patients would have to start taking it “very, very early,” Savas said — up to 20 years before elevated amyloid-beta 42 levels would be detected.

Advertisement

CLICK HERE FOR MORE HEALTH STORIES

“You couldn’t take this when you already have dementia, because the brain has already undergone a number of irreversible changes and a lot of cell death,” the researcher noted.

The researchers also did a deep dive into previous human clinical data to determine whether Alzheimer’s patients who were taking the anti-seizure drug had slower cognitive decline. They reported that the patients in that category had a “significant delay” in the span from cognitive decline to death compared to those not taking the drug.

“This analysis supports the positive effect of levetiracetam to slow the progression of Alzheimer’s pathology,” the researcher said. (iStock)

“Although the magnitude of change was small (on the scale of a few years), this analysis supports the positive effect of levetiracetam to slow the progression of Alzheimer’s pathology,” Savas said.

Advertisement

Looking ahead, the research team aims to find people who have genetic forms of Alzheimer’s to participate in testing, Savas said.

Limitations and caveats

The study had several limitations, including that it relied on animal models and cultured cells, with no human trials conducted.

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

Because the study was observational in nature, it can’t prove that the medication caused the prevention of the toxic brain proteins, the researchers acknowledged.

Savas noted that levetiracetam “is not perfect,” cautioning that it breaks down in the body very quickly.

Advertisement

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

The team is currently working to create a “better version” that would last longer in the body and “better target the mechanism that prevents the production of the plaques.”

“You couldn’t take this when you already have dementia, because the brain has already undergone a number of irreversible changes and a lot of cell death.”

The medication’s common documented side effects include drowsiness, weakness, dizziness, irritability, headache, loss of appetite and nasal congestion.

It has also been linked to potential mood and behavior changes, including anxiety, depression, agitation and aggression, according to the prescribing information. In rare cases, it could lead to severe allergic reactions, skin reactions, blood disorders and suicidal ideation.

Advertisement

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

Funding for the study was provided by the National Institutes of Health and the Cure Alzheimer’s Fund.

Fox News Digital reached out to the drug manufacturer and the researchers for comment.

Related Article

Alzheimer’s decline could slow dramatically with one simple daily habit, study finds
Continue Reading

Trending